Mabwell Announces FDA Fast Track Designation to 9MW3011

Mabwell has announced that the FDA has granted Fast Track Designation (FTD) to their drug, 9MW3011, for the treatment of patients with polycythaemia vera (PV).

9MW3011 has also received approval for clinical study by both the National Medical Products Administration (NMPA) in China and the FDA in the United States. In March 2023, the first person was dosed in the clinical study conducted in China.

9MW3011 is an anti-TMPRSS6 antibody that was developed at the San Diego Innovation and R&D Centre of Mabwell. It works by upregulating the level of hepcidin expressed by hepatocytes through specific binding. This action inhibits the absorption and release of iron and lowers serum iron levels, thus regulating iron homoeostasis in the body.

The drug's proposed indications include β-thalassaemia and polycythaemia vera, both of which are conditions related to abnormal blood cell production and iron metabolism. Currently, there are no mature and effective macromolecular drugs available for these indications.

In terms of commercialisation, Mabwell has granted exclusive rights to develop and commercialise 9MW3011 in the United States, Europe, and other territories, excluding Greater China and Southeast Asia.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!